Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial
阿法替尼联合贝伐珠单抗治疗对奥希替尼耐药的EGFR突变型非小细胞肺癌患者:一项开放标签、II期、多中心、单臂试验方案
期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.13503
Kobayashi, Nobuaki; Hashimoto, Hisashi; Kamimaki, Chisato; Nagasawa, Ryo; Tanaka, Katsushi; Kubo, Sousuke; Katakura, Seigo; Chen, Hao; Hirama, Nobuyuki; Ushio, Ryota; Aoki, Ayako; Nakashima, Kentaro; Teranishi, Shuhei; Manabe, Saki; Watanabe, Hiroki; Horita, Nobuyuki; Watanabe, Keisuke; Hara, Yu; Yamamoto, Masaki; Kudo, Makoto; Piao, Hongmei; Kaneko, Takeshi